NEURO61

Session information

[held on paper]Oral Session

[O-36] Oral Session 36
Cerebrovascular disease (clinical research 6)

Shoji Matsumoto1, Ayuko Yasuda2, Ichiro Nakahra1, Hiroshi Koyama3, Daisuke Koike2, Shinpei Okita1, Jun-ichi Kira4 (1.Department of Comprehensive Strokology, Fujita Health University School of Medicine, 2.Department of Quality and Safety in Healthcare, Fujita Health University School of Medicine, 3.Graduate School of Industrial Technology, Advanced Institute of Industrial Technology, 4.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University)

Hidesato Takezawa1,2, Yukihiro Hidaka1,2, Masanori Cho1,2, Tetsuya Katsumori3, Ryosuke Fukazawa1, Yasufumi Takagi4, Toyonobu Maegawa4, Yukihiro Goto4, Shigeomi Yokoya4, Hideki Oka4, Akihiko Hino4, Akihiro Fujii1 (1.Department of Neurology, Saiseikai Shiga Hospital, 2.NeuroEndovascular Therapy center, Saiseikai Shiga Hospital, 3.Department of Radiology, Saiseikai Shiga Hospital, 4.Department of Neurosurgery, Saiseikai Shiga Hospital)